Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer

BACKGROUND: This open-label study evaluated the efficacy and safety of a new leuprolide acetate 45 mg 6-month depot formulation in 151 men with prostate cancer who received 2 intramuscular injections administered 24 weeks apart. METHODS: The primary efficacy measurement was the proportion of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitz, A, Young, J M, Larsen, L, Mattia-Goldberg, C, Donnelly, J, Chwalisz, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278745/
https://www.ncbi.nlm.nih.gov/pubmed/22025196
http://dx.doi.org/10.1038/pcan.2011.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278745/
https://www.ncbi.nlm.nih.gov/pubmed/22025196
http://dx.doi.org/10.1038/pcan.2011.50

Ejemplares similares